ACE2 | Angiotensin I converting enzyme 2 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ACY3 | Aspartoacylase (aminocyclase) 3 | Enzymes
| | | | | Tissue enhanced |
AKR1B10 | Aldo-keto reductase family 1, member B10 (aldose reductase) | | | | | | Tissue enhanced |
AKR1B15 | Aldo-keto reductase family 1, member B15 | | | | | | Tissue enhanced |
ANXA13 | Annexin A13 | Plasma proteins
| | | | | Tissue enhanced |
ARHGDIG | Rho GDP dissociation inhibitor (GDI) gamma | | | | | | Tissue enhanced |
B3GALT5 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 | Predicted secreted proteins
| | | | | Tissue enhanced |
CDHR5 | Cadherin-related family member 5 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CYP4F12 | Cytochrome P450, family 4, subfamily F, polypeptide 12 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
DAB1 | Dab, reelin signal transducer, homolog 1 (Drosophila) | | | | | | Tissue enhanced |
DDC | Dopa decarboxylase (aromatic L-amino acid decarboxylase) | Disease related genes Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
EPCAM | Epithelial cell adhesion molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
EXOC3L4 | Exocyst complex component 3-like 4 | | | | | | Tissue enhanced |
FAM211A | Family with sequence similarity 211, member A | | | | | | Tissue enhanced |
FOLH1 | Folate hydrolase (prostate-specific membrane antigen) 1 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GDA | Guanine deaminase | Enzymes Plasma proteins
| | | | | Tissue enhanced |
HIST1H2BH | Histone cluster 1, H2bh | | | | | | Tissue enhanced |
HNF1A | HNF1 homeobox A | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enhanced |
HNF4A | Hepatocyte nuclear factor 4, alpha | Disease related genes Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
HRASLS2 | HRAS-like suppressor 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
LGALS4 | Lectin, galactoside-binding, soluble, 4 | Cancer-related genes Plasma proteins
| | | | | Tissue enhanced |
MIA2 | Melanoma inhibitory activity 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
MISP | Mitotic spindle positioning | Cytoskeleton related proteins
| | | | | Tissue enhanced |
MME | Membrane metallo-endopeptidase | Cancer-related genes Candidate cardiovascular disease genes CD markers Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MYO7B | Myosin VIIB | Cytoskeleton related proteins
| | | | | Tissue enhanced |
ONECUT2 | One cut homeobox 2 | Transcription factors
| | | | | Tissue enhanced |
PLS1 | Plastin 1 | | | | | | Tissue enhanced |
PRR15 | Proline rich 15 | | | | | | Tissue enhanced |
PRR15L | Proline rich 15-like | | | | | | Tissue enhanced |
REG1B | Regenerating islet-derived 1 beta | Predicted secreted proteins
| | | | | Tissue enhanced |
RNF186 | Ring finger protein 186 | Predicted membrane proteins
| | | | | Tissue enhanced |
RP11-1220K2.2 | Putative inactive maltase-glucoamylase-like protein LOC93432 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
RP11-407N17.3 | CTAGE family member 5 isoform 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
SCT | Secretin | Predicted secreted proteins
| | | | | Tissue enhanced |
SLC28A2 | Solute carrier family 28 (concentrative nucleoside transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SOWAHA | Sosondowah ankyrin repeat domain family member A | Predicted secreted proteins
| | | | | Tissue enhanced |
TMEM229A | Transmembrane protein 229A | Predicted membrane proteins
| | | | | Tissue enhanced |
TMEM45B | Transmembrane protein 45B | Predicted membrane proteins
| | | | | Tissue enhanced |
TNFRSF11A | Tumor necrosis factor receptor superfamily, member 11a, NFKB activator | CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
TRPM5 | Transient receptor potential cation channel, subfamily M, member 5 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
TSPAN8 | Tetraspanin 8 | Cancer-related genes Predicted membrane proteins
| | | | | Tissue enhanced |